Romlusevimab
Product Specifications
CAS Number
2509447-08-7
Target
SARS-CoV
Related Pathways
Microbiology/Virology
Purity
1
Bioactivity
Romlusevimab (BRII-198) is a recombinant antibody targeting the spike protein of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), with antiviral activity, used for research on COVID-19 infection.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS9247748-01 0.1 mg
Anti-Hepcidin/HAMP Reference Antibody (Ludwig-Maximilians U. anti_Hepsin)
Ask
View Details MBS9247748-02 5x 0.1 mg
Anti-Hepcidin/HAMP Reference Antibody (Ludwig-Maximilians U. anti_Hepsin)
Ask
View Details MBS7087238 Inquire
Recombinant Acinetobacter sp. NADH-quinone oxidoreductase subunit K (nuoK), partial
Ask
View Details 
